背景:骨质减少,由绝经后妇女雌激素缺乏(PMW)引起,降低骨矿物质密度(BMD)并增加骨骼脆性。它影响了大约一半的老年妇女的社会和身体健康。PMW经历疼痛和残疾,影响他们健康相关的生活质量(QoL)和功能。这项研究旨在确定基于Kinect的虚拟现实训练(VRT)对骨量减少的PMW的物理性能和QoL的影响。
方法:这项研究是一项前瞻性的,双臂,并行设计,随机对照试验。该试验招募了52名参与者,每组随机分配26个。实验组接受基于Kinect的VRT,每周三次,持续24周,每次持续45分钟。两组都被指示每天在外面进行30分钟的步行。物理性能通过计时测试(TUG)测量,功能到达测试(FRT),五次坐立测试(FTSST),改进的坐姿和到达测试(MSRT),动态握力(DHGS),非动态握力(NDHGS),BORG评分和呼吸困难指数。EscaladeCalidaddevida骨质疏松症(ECOS-16)问卷测量了QoL。在基线时评估身体表现和生活质量指标,12周后,24周后。数据在SPSS25上进行分析。
结果:PMW参与者的平均年龄为58.00±5.52岁。在组内比较中,所有结果变量(TUG,FRT,FTSST,MSRT,DHGS,NDHGS,BORG得分,呼吸困难,和ECOS-16)在实验组的第12周和第24周以及基线和第24周之间均显示出从基线的显着改善(p<0.001)。在对照组中,除FRT(第12周至第24周)外,所有结局变量在第12周和第24周以及基线与第24周之间均显示较基线有统计学意义的改善(p<0.001).在组间比较中,实验组在所有时间点的大多数结果变量都比对照组显着改善(p<0.001),表明基于Kinect的VRT的积极附加效果。
结论:该研究得出的结论是,实验组和对照组的身体表现和QoL指标都得到了改善。然而,在群体比较中,这些变量在实验组中显示出更好的结果。因此,基于Kinect的VRT是一种替代且可行的干预措施,可改善骨质减少的PMW的身体表现和QoL。这种新颖的方法可能广泛适用于即将进行的研究,考虑到人们对基于虚拟现实的康复治疗的兴趣日益增加。
BACKGROUND: Osteopenia, caused by estrogen deficiency in
postmenopausal women (PMW), lowers Bone Mineral Density (BMD) and increases bone fragility. It affects about half of older women\'s social and physical health. PMW experience pain and disability, impacting their health-related Quality of Life (QoL) and function. This
study aimed to determine the effects of Kinect-based Virtual Reality Training (VRT) on physical performance and QoL in PMW with osteopenia.
METHODS: The
study was a prospective, two-arm, parallel-design, randomized controlled
trial. Fifty-two participants were recruited in the
trial, with 26 randomly assigned to each group. The experimental group received Kinect-based VRT thrice a week for 24 weeks, each lasting 45 min. Both groups were directed to participate in a 30-min walk outside every day. Physical performance was measured by the Time Up and Go Test (TUG), Functional Reach Test (FRT), Five Times Sit to Stand Test (FTSST), Modified Sit and Reach Test (MSRT), Dynamic Hand Grip Strength (DHGS), Non-Dynamic Hand Grip Strength (NDHGS), BORG Score and Dyspnea Index. Escala de Calidad de vida Osteoporosis (ECOS-16) questionnaire measured QoL. Both physical performance and QoL measures were assessed at baseline, after 12 weeks, and after 24 weeks. Data were analyzed on SPSS 25.
RESULTS: The mean age of the PMW participants was 58.00 ± 5.52 years. In within-group comparison, all outcome variables (TUG, FRT, FTSST, MSRT, DHGS, NDHGS, BORG Score, Dyspnea, and ECOS-16) showed significant improvements (p < 0.001) from baseline at both the 12th and 24th weeks and between baseline and the 24th week in the experimental group. In the control group, all outcome variables except FRT (12th week to 24th week) showed statistically significant improvements (p < 0.001) from baseline at both the 12th and 24th weeks and between baseline and the 24th week. In between-group comparison, the experimental group demonstrated more significant improvements in most outcome variables at all points than the control group (p < 0.001), indicating the positive additional effects of Kinect-based VRT.
CONCLUSIONS: The
study concludes that physical performance and QoL measures were improved in both the experimental and control groups. However, in the group comparison, these variables showed better results in the experimental group. Thus, Kinect-based VRT is an alternative and feasible intervention to improve physical performance and QoL in PMW with osteopenia. This novel approach may be widely applicable in upcoming studies, considering the increasing interest in virtual reality-based therapy for rehabilitation.